{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:31:21Z","timestamp":1793946681142,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009568","name":"Universidade Estadual Paulista","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["RED-00110-23"],"award-info":[{"award-number":["RED-00110-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmc.2026.118658","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:17:07Z","timestamp":1775809027000},"page":"118658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advancements in diverse chemical scaffolds for antimalarial drug discovery: a ten-year hit-to-lead retrospective"],"prefix":"10.1016","volume":"138","author":[{"given":"Marcelo Augusto Pereira","family":"Janu\u00e1rio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Davison","family":"da Silva Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Luis Cardoso","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Oliveira","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Mar\u00e7al","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"de Oliveira Rezende J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118658_bb0005","series-title":"World malaria report 2025: addressing the threat of antimalarial drug resistance","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.bmc.2026.118658_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009077","article-title":"Asymptomatic Plasmodium vivax malaria in the Brazilian Amazon: submicroscopic parasitemic blood infects Nyssorhynchus darlingi","volume":"15","author":"Almeida","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2026.118658_bb0015","series-title":"Global Report on Neglected Tropical Diseases 2024","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.bmc.2026.118658_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1122411","article-title":"Malaria and leishmaniasis: updates on co-infection","volume":"14","author":"Ornellas-Garcia","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2026.118658_bb0025","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMra2405313","article-title":"Malaria","volume":"392","author":"Daily","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2026.118658_bb0030","article-title":"Morphological atypia and molecular profile of Plasmodium vivax: findings from an outbreak in the Brazilian Amazon","volume":"30","author":"Alves AC de J","year":"2023","journal-title":"Parasite"},{"key":"10.1016\/j.bmc.2026.118658_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12936-023-04444-2","article-title":"Impact of insecticide resistance on malaria vector competence: a literature review","volume":"22","author":"Suh","year":"2023","journal-title":"Malar J"},{"key":"10.1016\/j.bmc.2026.118658_bb0040","doi-asserted-by":"crossref","unstructured":"Belete TM. <p>recent progress in the development of new antimalarial drugs with novel targets<\/p>. Drug Des Devel Ther 2020;Volume 14:3875\u20133889. doi:https:\/\/doi.org\/10.2147\/DDDT.S265602.","DOI":"10.2147\/DDDT.S265602"},{"key":"10.1016\/j.bmc.2026.118658_bb0045","series-title":"World Malaria Report 2023","year":"2023"},{"key":"10.1016\/j.bmc.2026.118658_bb0050","article-title":"A review of malaria molecular markers for drug resistance in Plasmodium falciparum and Plasmodium vivax in China","volume":"13","author":"Wang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bmc.2026.118658_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/acph-2023-0001","article-title":"Recent approaches in the drug research and development of novel antimalarial drugs with new targets","volume":"73","author":"Chinnappanna","year":"2023","journal-title":"Acta Pharma"},{"key":"10.1016\/j.bmc.2026.118658_bb0060","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa2211803","article-title":"Evolution of partial resistance to artemisinins in malaria parasites in Uganda","volume":"389","author":"Conrad","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2026.118658_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2023.100496","article-title":"Molecular detection of antimalarial resistance in plasmodium vivax isolates from a tertiary care setting in Puducherry","volume":"47","author":"Stanley","year":"2024","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.bmc.2026.118658_bb0070","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: Progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2026.118658_bb0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ddtec.2021.08.001","article-title":"From computer-aided drug discovery to computer-driven drug discovery","volume":"39","author":"Frye","year":"2021","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.bmc.2026.118658_bb0080","doi-asserted-by":"crossref","unstructured":"Lipinski CA. Overview of hit to lead: the medicinal chemists role from HTS retest to lead optimization hand off. In: 2009:1\u201324. doi:https:\/\/doi.org\/10.1007\/7355_2009_4.","DOI":"10.1007\/7355_2009_4"},{"key":"10.1016\/j.bmc.2026.118658_bb0085","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2026.118658_bb0090","article-title":"The european federation for medicinal chemistry and chemical biology (EFMC) best practice initiative: hit to lead","volume":"20","author":"Quancard","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118658_bb0095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/acsmedchemlett.7b00030","article-title":"Discovery of antimalarial azetidine-2-carbonitriles that inhibit p. falciparum dihydroorotate dehydrogenase","volume":"8","author":"Maetani","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118658_bb0100","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1021\/acsomega.8b01573","article-title":"Isoxazolopyrimidine-based inhibitors of plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity","volume":"3","author":"Kokkonda","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2026.118658_bb0105","doi-asserted-by":"crossref","unstructured":"Sula I, Jihwaprani MC, Ahmad I, et al. Evaluating the safety, pharmacokinetics, and antiparasitic activity of DSM265, a novel antimalarial Plasmodium dihydroorotate dehydrogenase inhibitor: a systematic review and meta-analysis of early clinical trials. Malar J Published online February 17, 2026. doi:https:\/\/doi.org\/10.1186\/s12936-026-05826-y.","DOI":"10.1186\/s12936-026-05826-y"},{"key":"10.1016\/j.bmc.2026.118658_bb0110","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1021\/acs.jmedchem.0c00311","article-title":"Lead optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series for the treatment of malaria","volume":"63","author":"Kokkonda","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0115","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/acs.jmedchem.1c00173","article-title":"Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series","volume":"64","author":"Palmer","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0120","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/acs.jmedchem.6b01641","article-title":"Antimalarial pyrido[1,2- a ]benzimidazoles: Lead optimization, parasite life cycle stage profile, mechanistic evaluation, killing kinetics, and in vivo oral efficacy in a mouse model","volume":"60","author":"Singh","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0125","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1021\/acs.jmedchem.8b01769","article-title":"Structure\u2013activity relationship studies and Plasmodium life cycle profiling identifies pan-active N -aryl-3-trifluoromethyl pyrido[1,2- a ]benzimidazoles which are efficacious in an in vivo mouse model of malaria","volume":"62","author":"Mayoka","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0130","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1021\/jm200227r","article-title":"Antimalarial pyrido[1,2- a ]benzimidazoles","volume":"54","author":"Ndakala","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0135","doi-asserted-by":"crossref","first-page":"13013","DOI":"10.1021\/acs.jmedchem.0c01411","article-title":"Identification of 2,4-disubstituted imidazopyridines as hemozoin formation inhibitors with fast-killing kinetics and in vivo efficacy in the plasmodium falciparum NSG mouse model","volume":"63","author":"Horatscheck","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0140","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1021\/acs.jmedchem.1c00354","article-title":"Antimalarial benzimidazole derivatives incorporating phenolic Mannich base side chains inhibit microtubule and hemozoin formation: structure\u2013activity relationship and in vivo oral efficacy studies","volume":"64","author":"Dziwornu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0145","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1021\/acs.jmedchem.8b00648","article-title":"Identification, characterization, and optimization of 2,8-Disubstituted-1,5-naphthyridines as novel plasmodium falciparum phosphatidylinositol-4-kinase inhibitors with in vivo efficacy in a humanized mouse model of malaria","volume":"61","author":"Kandepedu","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmc.2026.118658_bb0155","doi-asserted-by":"crossref","first-page":"9890","DOI":"10.1021\/acs.jmedchem.6b01265","article-title":"Identification of a potential antimalarial drug candidate from a series of 2-Aminopyrazines by optimization of aqueous solubility and potency across the parasite life cycle","volume":"59","author":"Le Manach","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0160","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.1021\/jm401278d","article-title":"Structure\u2013activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-Diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity","volume":"56","author":"Younis","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0165","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1021\/acsbiomedchemau.5c00058","article-title":"Indole-2-carboxamides optimization for antiplasmodial activity","volume":"5","author":"Kumar","year":"2025","journal-title":"ACS Bio & Med Chem Au"},{"key":"10.1016\/j.bmc.2026.118658_bb0170","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1021\/acs.jmedchem.5b00434","article-title":"Carbamoyl triazoles, known serine protease inhibitors, are a potent new class of antimalarials","volume":"58","author":"McConville","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0175","doi-asserted-by":"crossref","first-page":"9672","DOI":"10.1021\/acs.jmedchem.6b00723","article-title":"Discovery of a quinoline-4-carboxamide derivative with a novel mechanism of action, multistage antimalarial activity, and potent in vivo efficacy","volume":"59","author":"Baraga\u00f1a","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0180","unstructured":"US Clinical Trials Registry CTN. Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2); 2026. https:\/\/clinicaltrials.gov\/study\/NCT05974267?rank=1."},{"key":"10.1016\/j.bmc.2026.118658_bb0185","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1021\/acs.jmedchem.6b00752","article-title":"Hit-to-Lead studies for the antimalarial tetrahydroisoquinolone carboxanilides","volume":"59","author":"Floyd","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0190","unstructured":"ClinicalTrials.gov ID NCT04709692. Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria. https:\/\/clinicaltrials.gov\/study\/NCT04709692. 2023."},{"key":"10.1016\/j.bmc.2026.118658_bb0195","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acs.jmedchem.0c02104","article-title":"Discovery of novel plasmodium falciparum HDAC1 inhibitors with dual-stage antimalarial potency and improved safety based on the clinical anticancer drug candidate quisinostat","volume":"64","author":"Li","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0200","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1021\/acs.jmedchem.6b00759","article-title":"ICI 56,780 optimization: structure\u2013activity relationship studies of 7-(2-phenoxyethoxy)-4(1H)-quinolones with antimalarial activity","volume":"59","author":"Maignan","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0205","doi-asserted-by":"crossref","first-page":"14121","DOI":"10.1021\/acs.jmedchem.2c01336","article-title":"Discovery and characterization of potent, efficacious, orally available antimalarial plasmepsin x inhibitors and preclinical safety assessment of UCB7362","volume":"65","author":"Lowe","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0210","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1021\/acs.jmedchem.8b01972","article-title":"4-aryl pyrrolidines as a novel class of orally efficacious antimalarial agents. Part 1: evaluation of 4-aryl- n -benzylpyrrolidine-3-carboxamides","volume":"62","author":"Meyers","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0215","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ejmech.2015.08.044","article-title":"Discovery and optimisation studies of antimalarial phenotypic hits","volume":"103","author":"Mital","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0220","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acsinfecdis.4c00659","article-title":"Tambjamines as fast-acting multistage antimalarials","volume":"10","author":"Kumar","year":"2024","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2026.118658_bb0225","doi-asserted-by":"crossref","first-page":"11746","DOI":"10.1021\/acs.jmedchem.5c00597","article-title":"Optimization of tambjamines active against multiple stages of malaria parasites","volume":"68","author":"Kumar","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0230","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1021\/acs.jmedchem.5b00560","article-title":"Synthesis and structure\u2013activity relationships of tambjamines and B-ring functionalized prodiginines as potent antimalarials","volume":"58","author":"Kancharla","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0235","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1021\/acs.jmedchem.1c00748","article-title":"Total synthesis and antimalarial activity of 2-( p -hydroxybenzyl)-prodigiosins, isoheptylprodigiosin, and geometric isomers of tambjamine MYP1 isolated from marine bacteria","volume":"64","author":"Kancharla","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0240","doi-asserted-by":"crossref","first-page":"19755","DOI":"10.1021\/acs.jmedchem.4c02093","article-title":"Optimization of B-ring-functionalized antimalarial tambjamines and prodiginines","volume":"67","author":"Kumar","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0245","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/sj.bjp.0703470","article-title":"Inhibition of HERG potassium channels by the antimalarial agent halofantrine","volume":"130","author":"Tie","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2026.118658_bb0250","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1021\/acs.jmedchem.5b00114","article-title":"A developability-focused optimization approach allows identification of in vivo fast-acting antimalarials: N -[3-[(Benzimidazol-2-yl)amino]propyl]amides","volume":"58","author":"Keurulainen","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0255","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1021\/acsomega.0c00327","article-title":"Lerisetron analogues with antimalarial properties: synthesis, structure\u2013activity relationship studies, and biological assessment","volume":"5","author":"Mueller","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2026.118658_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914480","article-title":"Structure\u2013activity relationships and antiplasmodial potencies of novel 3,4-disubstituted 1,2,5-oxadiazoles","volume":"24","author":"Hochegger","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118658_bb0265","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1021\/acs.jmedchem.6b01441","article-title":"The discovery of novel antimalarial aminoxadiazoles as a promising nonendoperoxide scaffold","volume":"60","author":"Sandoval","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0270","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1021\/acs.jmedchem.8b01961","article-title":"Discovery and structural optimization of acridones as broad-Spectrum antimalarials","volume":"62","author":"Dodean","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0275","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1021\/acs.jmedchem.0c00539","article-title":"Lead optimization of second-generation acridones as broad-Spectrum antimalarials","volume":"63","author":"Kancharla","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129992","article-title":"Pyridine and pyrimidine hybrids as privileged scaffolds in antimalarial drug discovery: a recent development","volume":"114","author":"Ravindar","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118658_bb0285","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1021\/acs.jmedchem.5b01156","article-title":"Structure\u2013activity relationship studies of orally active antimalarial 2,4-diamino-thienopyrimidines","volume":"58","author":"Gonz\u00e0lez Cabrera","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0290","doi-asserted-by":"crossref","unstructured":"Hameed P. S, Solapure S, Patil V, et al. Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate. Nat Commun 2015;6:6715. doi:https:\/\/doi.org\/10.1038\/ncomms7715.","DOI":"10.1038\/ncomms7715"},{"key":"10.1016\/j.bmc.2026.118658_bb0295","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1021\/acs.jmedchem.1c01995","article-title":"Discovery and preclinical pharmacology of INE963, a potent and fast-acting blood-stage antimalarial with a high barrier to resistance and potential for single-dose cures in uncomplicated malaria","volume":"65","author":"Taft","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0300","unstructured":"ClinicalTrials.gov ID NCT05750628. Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria (PLATINUM). https:\/\/clinicaltrials.gov\/study\/NCT05750628. 2025."},{"key":"10.1016\/j.bmc.2026.118658_bb0305","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/cmdc.201900329","article-title":"Substituted aminoacetamides as novel leads for malaria treatment","volume":"14","author":"Norcross","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118658_bb0310","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.ejmech.2016.12.024","article-title":"Novel inhibitors of plasmodium falciparum based on 2,5-disubstituted furans","volume":"126","author":"Krake","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118658_bb0315","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpddr.2017.02.002","article-title":"4-nitro styrylquinoline is an antimalarial inhibiting multiple stages of plasmodium falciparum asexual life cycle","volume":"7","author":"Roberts","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.bmc.2026.118658_bb0320","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1021\/acs.jmedchem.0c00858","article-title":"Synthesis, structure\u2013activity relationship, and antimalarial efficacy of 6-chloro-2-arylvinylquinolines","volume":"63","author":"Huang","year":"2020","journal-title":"J Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:01:34Z","timestamp":1793944894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626001148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"alternative-id":["S0968089626001148"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118658","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in diverse chemical scaffolds for antimalarial drug discovery: a ten-year hit-to-lead retrospective","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118658"}}